The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126568231 12656823 1 I 20160809 20160816 20160816 EXP NL-MYLANLABS-2016M1033916 MYLAN VAN AALST J, TEERNSTRA OP, WEBER WE, RIJKERS K. AN UNUSUAL CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT BEING WEANED FROM INTRATHECAL MORPHINE. INT-MED-CASE-REP-J 2016;9:117-120. 0.00 Y 0.00000 20160816 OT NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126568231 12656823 1 PS CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 Unknown 300 MG FOUR TIMES DAILY Y U 203063
126568231 12656823 2 SS MORPHINE MORPHINE 1 Intrathecal 3.5 MG PER DAY (EQUIVALENT OF 1000 MG ORALLY). U 0
126568231 12656823 3 SS AUGMENTIN AMOXICILLINCLAVULANATE POTASSIUM 1 Unknown ON HER OWN INITIATIVE 500/125 MG FOUR TIMES DAILY; LATER 1000/200MG QID AT HOSPITAL Y U 0
126568231 12656823 4 C CLONIDINE. CLONIDINE 1 Oral Y U 0 .15 MG QID
126568231 12656823 5 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral Y U 0 20 MG QID
126568231 12656823 6 C DUROGESIC FENTANYL 1 Cutaneous 100MCG/HOUR Y U 0
126568231 12656823 7 C DIAZEPAM. DIAZEPAM 1 Oral Y U 0 5 MG QID
126568231 12656823 8 C SEVOFLURANE. SEVOFLURANE 1 Unknown U 0
126568231 12656823 9 C PROPOFOL. PROPOFOL 1 Unknown U 0
126568231 12656823 10 C SUFENTANIL SUFENTANIL 1 Unknown U 0
126568231 12656823 11 C ROCURONIUM BROMIDE. ROCURONIUM BROMIDE 1 Unknown U 0
126568231 12656823 12 C AMITRIPTYLINE AMITRIPTYLINE 1 Unknown Y U 0 25 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126568231 12656823 1 Product used for unknown indication
126568231 12656823 2 Amputation stump pain
126568231 12656823 3 Product used for unknown indication
126568231 12656823 7 Muscle spasms
126568231 12656823 8 General anaesthesia
126568231 12656823 9 General anaesthesia
126568231 12656823 10 General anaesthesia
126568231 12656823 11 General anaesthesia

Outcome of event

Event ID CASEID OUTC COD
126568231 12656823 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126568231 12656823 Drug withdrawal syndrome
126568231 12656823 Posterior reversible encephalopathy syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found